Variant report
Variant | esv3343883 |
---|---|
Chromosome Location | chr3:97917974-97928437 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MINA-6 | chr3:97923366-97923509 | NONHSAT090787 |
2 | lnc-MINA-6 | chr3:97925331-97925450 | NONHSAT090787 |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5H3P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532968566 | chr3:97917988-97917989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541742033 | chr3:97918025-97918026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186422719 | chr3:97918068-97918069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572273081 | chr3:97918079-97918080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138431203 | chr3:97918107-97918108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147043392 | chr3:97918121-97918122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201534545 | chr3:97918122-97918123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs3835149 | chr3:97918123-97918124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs67716134 | chr3:97918124-97918125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563752283 | chr3:97918136-97918137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532856965 | chr3:97918166-97918167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543162278 | chr3:97918168-97918169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114416729 | chr3:97918191-97918192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs58929043 | chr3:97918222-97918223 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs548517166 | chr3:97918233-97918234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2291810 | chr3:97918267-97918268 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs549347373 | chr3:97918287-97918288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547802395 | chr3:97918298-97918299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569510959 | chr3:97918300-97918301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377002246 | chr3:97918313-97918314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539917620 | chr3:97918314-97918315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556728146 | chr3:97918337-97918338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78537156 | chr3:97918355-97918356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370165632 | chr3:97918370-97918371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539663298 | chr3:97918392-97918393 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191725448 | chr3:97918404-97918405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572265054 | chr3:97918448-97918449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141879449 | chr3:97918467-97918468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557330467 | chr3:97918486-97918487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181506681 | chr3:97918489-97918490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72927072 | chr3:97918535-97918536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566565237 | chr3:97918547-97918548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563015155 | chr3:97918559-97918560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9840421 | chr3:97918560-97918561 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs542365844 | chr3:97918572-97918573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377520899 | chr3:97918603-97918604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562181852 | chr3:97918606-97918607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9879316 | chr3:97918614-97918615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs186441131 | chr3:97918638-97918639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564457175 | chr3:97918701-97918702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533330052 | chr3:97918706-97918707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190713301 | chr3:97918734-97918735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554233661 | chr3:97918742-97918743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570086826 | chr3:97918752-97918753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535586900 | chr3:97918781-97918782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549153983 | chr3:97918782-97918783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565785766 | chr3:97918825-97918826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150227664 | chr3:97918852-97918853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12490755 | chr3:97918853-97918854 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs62267814 | chr3:97918860-97918861 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:97917800-97918000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr3:97917800-97918000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr3:97917800-97918600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
4 | chr3:97917800-97927600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr3:97923600-97927600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr3:97926400-97926600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr3:97926600-97927600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr3:97927600-97927800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr3:97927600-97928200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr3:97927600-97928400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr3:97927600-97928800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr3:97927600-97928800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr3:97927800-97928200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr3:97928200-97928400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr3:97928200-97932200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr3:97928200-97936800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr3:97928400-97932200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |